Preparation method and application of artificial blood vessel surface coating
Through electrostatic spraying technology, the dense polymer layer is sprayed on the surface of artificial blood vessels, which solves the problem of polymer products causing inflammation during the degradation process of electrospinning artificial blood vessels, and achieves both permeability and rapid degradation, improving the applicability and safety of blood vessels sex.
Patent Information
- Application Number
- CN202410998322.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-12
AI Technical Summary
During the degradation process of existing electrospun artificial blood vessels, polymer products may trigger an inflammatory response, resulting in re-stenosis of the blood vessels, and it is difficult to take into account both the high porosity and the ability to block blood penetration.
Using electrostatic spray technology to spray a dense polymer layer on the surface of artificial blood vessels, by controlling the polymer concentration and spraying time, a coating with controllable permeability and rapid degradation is formed, and degradable polymers such as polylactic acid, polyhydroxybutyrate, etc. , combined with a vacuum drying box to heat and dry.
It improves the permeability and degradation speed of artificial blood vessels, meets the needs of different application scenarios, reduces inflammatory responses, and prolongs the autologous vascular regeneration cycle.
Smart Images

Figure BDA0004960877380000071 
Figure BDA0004960877380000081 
Figure HDA0004960877390000011
Abstract
Description
Technical Field
[0001] The invention relates to the field of medical devices, and in particular to a preparation method of an artificial blood vessel surface coating and application thereof. Background Art
[0002] With the development of society and the change of people's dietary structure, cardiovascular disease has become one of the main factors endangering human health. About 15 million people die from cardiovascular and cerebrovascular diseases every year, ranking first among all causes of death. At present, artificial blood vessels are an effective treatment for diseases such as vascular stenosis and aneurysms, but due to the limited resources of autologous blood vessels, a large number of artificial blood vessels are needed clinically. Degradable artificial blood vessels have become the development trend of the next generation of artificial blood vessels because of their characteristics of slow degradation after implantation and no exogenous substances remaining.
[0003] Electrospinning is a material preparation process for processing ultrafine fibers. The fibers produced by the electrospinning process can form a pore structure with a size comparable to that of cells, thus allowing cells to proliferate inside the fibers. The electrospinning process has the ability to act as a tissue engineering scaffold to induce cell proliferation within the fibers and reconstruct tissues. Based on the characteristics of electrospun fibers, degradable electrospun artificial blood vessels can take into account the advantages of temporary replacement of blood vessels, no exogenous substance residue, and autologous blood vessel regeneration, and have been widely studied.
[0004] After being implanted in the human body, artificial blood vessels need to block blood from penetrating outside the tube. Therefore, permeability is an important factor in considering artificial blood vessels. However, the high porosity of electrospun fibers and the ability to block blood penetration are contradictory. Therefore, in the prior art PCT / CN2020 / 072101, a layer of dense polymer film is sprayed on the surface of electrospun artificial blood vessels to block blood penetration to improve the anti-permeability of artificial blood vessels. However, for degradable electrospun artificial blood vessels, completely dense film-like polymers have a longer degradation cycle than fibrous polymers, and artificial blood vessels will produce some degradation products during the degradation process. These metabolites may cause inflammatory reactions. Long-term mild inflammation can promote excessive cell proliferation, thereby causing blood vessels to narrow again. Therefore, on the basis of meeting the permeability of artificial blood vessels, using polymers with faster degradation rates and spraying a coating with controllable density on the surface, the preparation of artificial blood vessels with controllable permeability can achieve the effect of taking into account both permeability and rapid degradation. Summary of the invention
[0005] In order to solve the problems in the prior art, the present invention provides a method for preparing a surface coating of an artificial blood vessel in a first aspect, comprising the following steps:
[0006] S1: prepare spray solution;
[0007] S2: electrostatic spraying;
[0008] S3: Heat and dry in a vacuum drying oven to obtain.
[0009] Preferably, the method for preparing the artificial blood vessel surface coating comprises the following steps:
[0010] S1: preparing a spray solution: dissolving a degradable polymer material in a solvent to form a polymer solution PS;
[0011] S2: Electrostatic spraying: The polymer solution PS is sprayed on the surface of the tubular fiber material by electrostatic spraying technology to form a dense polymer layer;
[0012] S3: heating and drying in a vacuum drying oven: placing the tubular fiber material sprayed in S2 in a vacuum drying oven for heating and drying to obtain the obtained product.
[0013] Preferably, the degradable polymer material in S1 is selected from one or more of polylactic acid, polyhydroxybutyrate, polyglycolic acid, polycaprolactone, polycarbonate, polyurethane, polybutylene succinate, polyglycolic acid, and polyethylene glycol.
[0014] Furthermore, the polylactic acid is L-polylactic acid.
[0015] Furthermore, the weight average molecular weight of the L-polylactic acid is 80,000.
[0016] Preferably, the weight average molecular weight of the polyethylene glycol is 100,000.
[0017] Preferably, the weight average molecular weight of the polycaprolactone is 120,000.
[0018] Preferably, the degradable polymer is selected from polyethylene glycol and polycaprolactone.
[0019] Preferably, the mass ratio of the polyethylene glycol to the polycaprolactone is 2:1.
[0020] Preferably, the solvent in S1 is selected from one or more of dichloromethane, chloroform, trifluoroacetic acid, hexafluoroisopropanol, dimethyl sulfoxide, acetone, ethyl acetate, tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, benzene, chlorobenzene, toluene, acetic acid, methanol, and ethanol.
[0021] Preferably, the mass fraction of the polymer in the polymer solution PS is 0.1% to 30%.
[0022] Furthermore, the mass fraction of the polymer in the polymer solution PS is 3% to 10%.
[0023] Preferably, the process parameters of the electrostatic spray in S2 are: solution supply rate 0.1-30 mL / h, nozzle voltage 3-30 kV; the distance between the nozzle and the fiber tube is 3-50 cm, the voltage at the fiber tube is -0.5-30 kV, the fiber tube rotation speed is 10-3000 rpm, and the electrostatic spray time is 0.5-24 h.
[0024] The polymer droplets sprayed by electrostatic spraying in the present invention will fall on the artificial blood vessel. After the solvent evaporates, the polymer therein will precipitate and deposit on the surface to form a dense film, blocking the gaps in the artificial blood vessel and increasing the osmotic pressure. The applicant has found through creative research that, without changing the solid content of the electrostatic spraying, by controlling the polymer concentration and the electrostatic spraying time, a more delicate surface PLLA material can be obtained, which better covers the surface of the artificial blood vessel and achieves a higher osmotic pressure.
[0025] The present invention does not limit the preparation of the tubular fiber material, including but not limited to preparation by electrostatic spinning technology, melt spinning fiber preparation, solution spinning fiber preparation, and natural fiber weaving preparation.
[0026] Preferably, the spraying in S2 is one of spraying of a single polymer solution and alternately spraying of multiple polymer solutions.
[0027] Preferably, the vacuum drying conditions in S3 are: pressure of 1 kPa-80 kPa, drying temperature of 25-80° C., and drying time of 4-24 h.
[0028] Furthermore, the vacuum drying conditions in S3 are: pressure of 1 kPa, drying temperature of 80° C., and drying time of 12 h.
[0029] Furthermore, the vacuum drying conditions in S3 are: pressure of 10 kPa, drying temperature of 20° C., and drying time of 24 h.
[0030] Furthermore, the vacuum drying conditions in S3 are: pressure of 10 kPa, drying temperature of 30° C., and drying time of 18 h.
[0031] The second aspect of the present invention provides an artificial blood vessel obtained by the above-mentioned preparation method, comprising an inner layer of a tubular fiber material and a dense polymer layer.
[0032] The third aspect of the present invention provides the use of the artificial blood vessel obtained by the above-mentioned preparation method, wherein the artificial blood vessel is used in aneurysm cavity isolation surgery, damaged blood vessel reinforcement surgery, and blood vessel transplantation surgery.
[0033] Beneficial Effects
[0034] 1. The present invention can improve the permeability of artificial blood vessels by controlling the polymer concentration and electrostatic spraying time without changing the solid content of the electrostatic spray.
[0035] 2. On the basis of satisfying the permeability of artificial blood vessels, the present invention uses a polymer with a faster degradation rate and sprays a coating with controllable density on the surface to prepare an artificial blood vessel with controllable permeability, which can achieve the effect of taking into account both permeability and rapid degradation.
[0036] 3. Artificial blood vessels have different requirements for permeability and degradation rate at different times and in different application scenarios. The present invention can meet the requirements for artificial blood vessels in different application scenarios and improve applicability by selecting different polymers and controlling the solution supply rate and electrostatic spray time.
[0037] 4. The raw materials of the artificial blood vessel prepared by the present invention are easily available, easy to prepare, low in cost, and easy to industrially produce. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 The SEM images of (a) an untreated artificial blood vessel and (bc) an artificial blood vessel treated by the method of Examples 1-3 are shown.
[0039] Figure 2 The SEM images are as follows: (a) an artificial blood vessel treated by the method of Example 4; (b) after being immersed in water for 4 hours; and (c) after being immersed in water for 36 hours.
[0040] Figure 3 The SEM images are as follows: (a) an artificial blood vessel treated by the method of Example 5; (b) after being immersed in water for 36 hours; and (c) after being immersed in water for 72 hours. DETAILED DESCRIPTION
[0041] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. The experimental methods in the examples without specifying specific conditions are carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used without specifying the manufacturer are all conventional products that can be purchased commercially.
[0042] Example 1
[0043] A first aspect of this embodiment provides a method for preparing an artificial blood vessel surface coating, comprising the following steps:
[0044] S1: Prepare spray solution: L-polylactic acid with a weight average molecular weight of 80,000 is dissolved in dichloromethane solution to form a polymer solution PS with a mass fraction of 6%;
[0045] S2: Electrostatic spraying: The polymer solution PS is sprayed on the surface of the tubular fiber material by electrostatic spraying technology to form a dense polymer layer. The solution supply rate is 0.5 mL / h, the nozzle voltage is 20 kV, the distance between the nozzle and the fiber tube is 10 cm, the voltage at the fiber tube is -5.0 kV, the fiber tube rotation speed is 150 rpm, and the electrostatic spraying time is 2 h.
[0046] S3: Heating and drying in a vacuum drying oven: The tubular fiber material sprayed in S2 is placed in a vacuum drying oven at a pressure of 1 kPa and a drying temperature of 80° C. and heated and dried for 12 hours to obtain the obtained product.
[0047] The second aspect of this embodiment provides an artificial blood vessel obtained by the above-mentioned preparation method, comprising an inner layer of a tubular fiber material and a dense polymer layer.
[0048] A third aspect of this embodiment provides the application of the artificial blood vessel obtained by the preparation method, wherein the artificial blood vessel is applied to aneurysm cavity isolation surgery, damaged blood vessel reinforcement surgery, and blood vessel transplantation surgery.
[0049] Example 2
[0050] A first aspect of this embodiment provides a method for preparing an artificial blood vessel surface coating, comprising the following steps:
[0051] S1: Prepare spray solution: L-polylactic acid with a weight average molecular weight of 80,000 is dissolved in dichloromethane solution to form a polymer solution PS with a mass fraction of 6%;
[0052] S2: Electrostatic spraying: The polymer solution PS is sprayed on the surface of the tubular fiber material by electrostatic spraying technology to form a dense polymer layer. The solution supply rate is 0.5 mL / h, the nozzle voltage is 20 kV, the distance between the nozzle and the fiber tube is 10 cm, the voltage at the fiber tube is -5.0 kV, the fiber tube rotation speed is 150 rpm, and the electrostatic spraying time is 4 h.
[0053] S3: Heating and drying in a vacuum drying oven: The tubular fiber material sprayed in S2 is placed in a vacuum drying oven at a pressure of 1 kPa and a drying temperature of 80° C. and heated and dried for 12 hours to obtain the obtained product.
[0054] The second aspect of this embodiment provides an artificial blood vessel obtained by the above-mentioned preparation method, comprising an inner layer of a tubular fiber material and a dense polymer layer.
[0055] A third aspect of this embodiment provides the application of the artificial blood vessel obtained by the preparation method, wherein the artificial blood vessel is applied to aneurysm cavity isolation surgery, damaged blood vessel reinforcement surgery, and blood vessel transplantation surgery.
[0056] Example 3
[0057] A first aspect of this embodiment provides a method for preparing an artificial blood vessel surface coating, comprising the following steps:
[0058] S1: Prepare spray solution: L-polylactic acid with a weight average molecular weight of 80,000 is dissolved in dichloromethane solution to form a polymer solution PS with a mass fraction of 4%;
[0059] S2: Electrostatic spraying: The polymer solution PS is sprayed on the surface of the tubular fiber material by electrostatic spraying technology to form a dense polymer layer. The solution supply rate is 0.5 mL / h, the nozzle voltage is 20 kV, the distance between the nozzle and the fiber tube is 10 cm, the voltage at the fiber tube is -5.0 kV, the fiber tube rotation speed is 150 rpm, and the electrostatic spraying time is 6 h.
[0060] S3: Heating and drying in a vacuum drying oven: The tubular fiber material sprayed in S2 is placed in a vacuum drying oven at a pressure of 1 kPa and a drying temperature of 80° C. and heated and dried for 12 hours to obtain the obtained product.
[0061] The second aspect of this embodiment provides an artificial blood vessel obtained by the above-mentioned preparation method, comprising an inner layer of a tubular fiber material and a dense polymer layer.
[0062] A third aspect of this embodiment provides the application of the artificial blood vessel obtained by the preparation method, wherein the artificial blood vessel is applied to aneurysm cavity isolation surgery, damaged blood vessel reinforcement surgery, and blood vessel transplantation surgery.
[0063] Example 4
[0064] A first aspect of this embodiment provides a method for preparing an artificial blood vessel surface coating, comprising the following steps:
[0065] S1: preparing the spray solution: dissolving polyethylene glycol with a weight average molecular weight of 100,000 in a dichloromethane solution to form a polymer solution PS with a mass fraction of 5%;
[0066] S2: Electrostatic spraying: The polymer solution PS is sprayed on the surface of the tubular fiber material by electrostatic spraying technology to form a dense polymer layer. The solution supply rate is 1 mL / h, the nozzle voltage is 15 kV, the distance between the nozzle and the fiber tube is 20 cm, the voltage at the fiber tube is -3.0 kV, the fiber tube rotation speed is 1000 rpm, and the electrostatic spraying time is 8 h.
[0067] S3: Heating and drying in a vacuum drying oven: The tubular fiber material sprayed in S2 is placed in a vacuum drying oven at a pressure of 10 kPa and a drying temperature of 20° C. and heated and dried for 24 hours to obtain the obtained product.
[0068] The second aspect of this embodiment provides an artificial blood vessel obtained by the above-mentioned preparation method, comprising an inner layer of a tubular fiber material and a dense polymer layer.
[0069] A third aspect of this embodiment provides the application of the artificial blood vessel obtained by the preparation method, wherein the artificial blood vessel is applied to aneurysm cavity isolation surgery, damaged blood vessel reinforcement surgery, and blood vessel transplantation surgery.
[0070] Example 5
[0071] A first aspect of this embodiment provides a method for preparing an artificial blood vessel surface coating, comprising the following steps:
[0072] S1: preparing a spray solution: dissolving polyethylene glycol with a weight average molecular weight of 100,000 and polycaprolactone with a weight average molecular weight of 120,000 in a chloroform solution to form a polymer solution PS, wherein the mass fractions of these two substances in the polymer solution PS are 4% and 2%, respectively;
[0073] S2: Electrostatic spraying: The polymer solution PS is sprayed on the surface of the tubular fiber material by electrostatic spraying technology to form a dense polymer layer. The solution supply rate is 3 mL / h, the nozzle voltage is 30 kV, the distance between the nozzle and the fiber tube is 25 cm, the voltage at the fiber tube is -10.0 kV, the fiber tube rotation speed is 100 rpm, and the electrostatic spraying time is 8 h.
[0074] S3: Heating and drying in a vacuum drying oven: The tubular fiber material sprayed in S2 is placed in a vacuum drying oven at a pressure of 10 kPa and a drying temperature of 30° C. and heated and dried for 18 hours to obtain the obtained product.
[0075] The second aspect of this embodiment provides an artificial blood vessel obtained by the above-mentioned preparation method, comprising an inner layer of a tubular fiber material and a dense polymer layer.
[0076] A third aspect of this embodiment provides the application of the artificial blood vessel obtained by the preparation method, wherein the artificial blood vessel is applied to aneurysm cavity isolation surgery, damaged blood vessel reinforcement surgery, and blood vessel transplantation surgery.
[0077] Performance Testing
[0078] Test sample:
[0079] Untreated artificial blood vessels and artificial blood vessels prepared in Examples 1-5 of the present invention.
[0080] test:
[0081] 1. Osmotic pressure test:
[0082] ① According to YY / T 0500-2021, the osmotic pressure test was performed on the untreated artificial blood vessels and the artificial blood vessels treated in Examples 1 to 3. The test results are shown in Table 1.
[0083] ② According to YY / T 0500-2021, the artificial blood vessel treated in Example 4 was immersed in pure water and subjected to an osmotic pressure test after treatment for 4 h and 36 h. The test results are shown in Table 2.
[0084] ③ According to YY / T 0500-2021, the artificial blood vessel treated in Example 5 was immersed in pure water and subjected to an osmotic pressure test after 36 h and 72 h of treatment. The test results are shown in Table 3.
[0085] Table 1
[0086] sample Untreated blood vessel Example 1 Example 2 Example 3 Osmotic pressure (kPa) 0.2 16 44 122
[0087] Table 2
[0088] sample Example 4 Soak in water for 4 hours Soak in water for 36 hours Osmotic pressure (kPa) 172 112 5.5
[0089] Table 3
[0090]
[0091]
[0092] from Figure 1 It can be seen that the surface of the artificial blood vessel after surface electrostatic spraying is covered with a layer of PLLA material, and the surface of Examples 1 and 2 is mainly PLLA material with a certain granularity. From Table 1, it can be seen that the osmotic pressure of the tube can be controlled by controlling the electrostatic spraying time. Comparative Example 3 shows that reducing the concentration of the PLLA solution without changing the solid content of the electrostatic spray (Example 2, 0.5mL / h, 4h, 6%; Example 3, 0.5mL / h, 6h, 4%) can obtain a more delicate surface PLLA material, better cover the surface of the artificial blood vessel, and achieve a higher osmotic pressure (122kPa).
[0093] from Figure 2 As can be seen in the figure, since PEG is a water-soluble polymer with high viscosity in water, PEG will slowly dissolve in water during the water immersion process, and the PEG on the surface of the artificial blood vessel will gradually disappear, and the fibrous structure of the lower layer will leak out. The osmotic pressure test (Table 2) shows that with the slow loss of PEG, the osmotic pressure of the artificial blood vessel gradually decreases. This process is more in line with the needs of artificial blood vessels after implantation in the human body. In other words, after the artificial blood vessel is implanted in the human body, the blood vessel should at least maintain a certain osmotic pressure (for example, the average aortic blood pressure is 120 mmHg, i.e. 16 kPa) to ensure that the blood does not penetrate. After the artificial blood vessel remains in the human body for several hours, the blood cells and immune cells in the blood will gradually cover and fill the artificial blood vessel, playing a certain role in blocking blood penetration. In this process, PEG gradually dissolves and is eventually absorbed by the human body in a short time, which does not have a negative effect on the degradation time of the artificial blood vessel.
[0094] from Figure 3 It can be seen that as the water treatment time increases, the dense layer on the surface of the artificial blood vessel is gradually lost, but it has not disappeared after 72 hours. This is because PCL is a water-insoluble degradable polymer, and PCL still adheres to the surface of the artificial blood vessel after PEG is dissolved. From Table 3, it can be seen that compared with Example 4, the osmotic pressure of the artificial blood vessel prepared in Example 5 is significantly higher after being soaked in water for 36 hours, and it still has a high osmotic pressure after 72 hours. Through the combination of multiple degradable polymers, the artificial blood vessel can provide the required osmotic pressure at different times after being implanted in the human body, and the rapidly degradable polymer material will not prolong the degradation cycle of the artificial blood vessel.
Claims
1. A method for preparing an artificial blood vessel surface coating, characterized in that: The following steps are involved: S1: prepare spray solution; S2: electrostatic spraying; S3: Heat and dry in a vacuum drying oven to obtain.
2. The method for preparing the surface coating of an artificial blood vessel according to claim 1, characterized in that: The following steps are involved: S1: preparing a spray solution: dissolving a degradable polymer material in a solvent to form a polymer solution PS; S2: Electrostatic spraying: The polymer solution PS is sprayed on the surface of the tubular fiber material by electrostatic spraying technology to form a dense polymer layer; S3: heating and drying in a vacuum drying oven: placing the tubular fiber material sprayed in S2 in a vacuum drying oven for heating and drying to obtain the obtained product.
3. The method for preparing the surface coating of an artificial blood vessel according to claim 2, characterized in that: The degradable polymer material in S1 is selected from one or more of polylactide, polyhydroxybutyrate, polyglycolic acid, polycaprolactone, polycarbonate, polyurethane, polybutylene succinate, polyglycolic acid, and polyethylene glycol.
4. The method for preparing the surface coating of an artificial blood vessel according to claim 2, characterized in that: The solvent in S1 is selected from one or more of dichloromethane, chloroform, trifluoroacetic acid, hexafluoroisopropanol, dimethyl sulfoxide, acetone, ethyl acetate, tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, benzene, chlorobenzene, toluene, acetic acid, methanol, and ethanol.
5. The method for preparing the surface coating of an artificial blood vessel according to claim 2, characterized in that: The mass fraction of the polymer in the polymer solution PS is 0.1% to 30%.
6. The method for preparing the surface coating of an artificial blood vessel according to claim 2, characterized in that: The process parameters of the electrostatic spray in S2 are: solution supply rate 0.1-30 mL / h, nozzle voltage 3-30 kV; the distance between the nozzle and the fiber tube is 3-50 cm, the voltage at the fiber tube is -0.5--30 kV, the fiber tube rotation speed is 10-3000 rpm, and the electrostatic spray time is 0.5-24 h.
7. The method for preparing the surface coating of an artificial blood vessel according to claim 2, characterized in that: The spraying in S2 is one of spraying of a single polymer solution and spraying of multiple polymer solutions alternately.
8. The method for preparing the surface coating of an artificial blood vessel according to claim 2, characterized in that: The vacuum drying conditions in S3 are: pressure of 1 kPa-80 kPa, drying temperature of 25-80° C., and drying time of 4-24 h.
9. An artificial blood vessel obtained by the preparation method according to any one of claims 1 to 8, characterized in that: It includes an inner layer of tubular fiber material and a dense polymer layer.
10. An application of an artificial blood vessel obtained by the preparation method according to claim 9, characterized in that: The artificial blood vessel is used in aneurysm cavity isolation surgery, damaged blood vessel reinforcement surgery, and blood vessel transplantation surgery.
